title: Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015.
authors.forename: Waldemar
authors.initials: W
authors.lastname: Halota
authors.forename: Robert
authors.initials: R
authors.lastname: Flisiak
authors.forename: Anna
authors.initials: A
authors.lastname: Boroń-Kaczmarska
authors.forename: Jacek
authors.initials: J
authors.lastname: Juszczyk
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Pawłowska
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Simon
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Tomasiewicz
authors.forename: Piotr
authors.initials: P
authors.lastname: Małkowski
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D019468:Disease Management; D017408:Guidelines as Topic; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D011044:Poland; D010818:Practice Patterns, Physicians' / Q000592:standards; D011320:Primary Health Care / Q000592:standards*; D011322:Primary Prevention / Q000592:standards*
chemical_list: D000998:Antiviral Agents